GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Magle Chemoswed Holding AB (OSTO:MAGLE) » Definitions » Enterprise Value

Magle Chemoswed Holding AB (OSTO:MAGLE) Enterprise Value : kr424.4 Mil (As of May. 22, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Magle Chemoswed Holding AB Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Magle Chemoswed Holding AB's Enterprise Value is kr424.4 Mil. Magle Chemoswed Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was kr18.4 Mil. Therefore, Magle Chemoswed Holding AB's EV-to-EBIT ratio for today is 23.06.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Magle Chemoswed Holding AB's Enterprise Value is kr424.4 Mil. Magle Chemoswed Holding AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was kr31.2 Mil. Therefore, Magle Chemoswed Holding AB's EV-to-EBITDA ratio for today is 13.60.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Magle Chemoswed Holding AB's Enterprise Value is kr424.4 Mil. Magle Chemoswed Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr171.1 Mil. Therefore, Magle Chemoswed Holding AB's EV-to-Revenue ratio for today is 2.48.


Magle Chemoswed Holding AB Enterprise Value Historical Data

The historical data trend for Magle Chemoswed Holding AB's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magle Chemoswed Holding AB Enterprise Value Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial - 498.20 355.40 329.91 325.38

Magle Chemoswed Holding AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 383.82 379.25 411.58 325.38 413.64

Competitive Comparison of Magle Chemoswed Holding AB's Enterprise Value

For the Biotechnology subindustry, Magle Chemoswed Holding AB's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magle Chemoswed Holding AB's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Magle Chemoswed Holding AB's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Magle Chemoswed Holding AB's Enterprise Value falls into.



Magle Chemoswed Holding AB Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Magle Chemoswed Holding AB's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Magle Chemoswed Holding AB's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magle Chemoswed Holding AB  (OSTO:MAGLE) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Magle Chemoswed Holding AB's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=424.438/18.403
=23.06

Magle Chemoswed Holding AB's current Enterprise Value is kr424.4 Mil.
Magle Chemoswed Holding AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr18.4 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Magle Chemoswed Holding AB's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=424.438/31.219
=13.60

Magle Chemoswed Holding AB's current Enterprise Value is kr424.4 Mil.
Magle Chemoswed Holding AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr31.2 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Magle Chemoswed Holding AB's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=424.438/171.134
=2.48

Magle Chemoswed Holding AB's current Enterprise Value is kr424.4 Mil.
Magle Chemoswed Holding AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr171.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magle Chemoswed Holding AB Enterprise Value Related Terms

Thank you for viewing the detailed overview of Magle Chemoswed Holding AB's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Magle Chemoswed Holding AB (OSTO:MAGLE) Business Description

Traded in Other Exchanges
N/A
Address
Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.

Magle Chemoswed Holding AB (OSTO:MAGLE) Headlines

No Headlines